Amedisys, Inc. (NASDAQ: AMED) reported Q4 EPS of $0.24, $0.02 better than the analyst estimate ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE